NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









LakeShore Biopharma Co., Ltd.

LakeShore Biopharma Co., Ltd.

Public

Last Round

M&A

Nov 4, 2025

Est. Valuation

$37M

Total Funding Raised

$334M

Company Overview

LakeShore Biopharma Co., Ltd. is a biopharmaceutical company that discovers, develops, manufactures, and commercializes vaccines and therapeutic biologics for infectious diseases and cancer.

Sector

Healthcare

AI Layer

Non-AI

Keywords

biopharmarabies vaccinevaccine developmentPIKA technology platforminfectious disease vaccinebiotechtherapeutic biologicsimmuno-oncologyB2Gcancer immunotherapyvaccine adjuvantclinical developmentHepatitis B vaccinegovernment contractsaluminum-free vaccinetake-private transaction

LakeShore Biopharma Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

LakeShore Biopharma Co., Ltd. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

LakeShore Biopharma Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&ANov 4, 2025
Private PlacementJul 8, 2025
Private PlacementFeb 9, 2024
M&AMar 16, 2023
PIPEMar 16, 2023
Debt
Mar 16, 2022

LakeShore Biopharma Co., Ltd. Investors

Notable investors and investment history

LakeShore Biopharma Co., Ltd. investors
InvestorRounds
Haitong International Securities GroupSeries B
Hillhouse InvestmentSeries B
MSA CapitalSeries B
F-Prime CapitalSeries B
AIHCSeries B
HaiTong XuYu International LimitedSeries A
CBC GroupDebt

LakeShore Biopharma Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

LakeShore Biopharma Co., Ltd. Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersChina
Year Founded2002
Last FundingNov 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.